BioSig Technologies, Inc.
BSGM
$0.736
-$0.0016-0.22%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | 13.00K | 14.00K | 12.00K | 1.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 13.00K | 14.00K | 12.00K | 1.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | 13.00K | 14.00K | 12.00K | 1.00K |
| SG&A Expenses | 2.76M | 4.91M | 2.88M | 4.91M | 2.82M |
| Depreciation & Amortization | 31.00K | 49.00K | 78.00K | 93.00K | 92.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.95M | 5.31M | 3.20M | 6.18M | 4.05M |
| Operating Income | -2.95M | -5.29M | -3.18M | -6.17M | -4.05M |
| Income Before Tax | -1.91M | -3.91M | -3.42M | -6.13M | -4.05M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.91M | -3.91M | -3.42M | -6.13M | -4.05M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -4.00K | 13.00K | 79.00K | -517.00K |
| Net Income | -1.91M | -3.92M | -3.40M | -6.05M | -4.57M |
| EBIT | -2.95M | -5.29M | -3.18M | -6.17M | -4.05M |
| EBITDA | -2.92M | -5.24M | -3.11M | -6.07M | -3.96M |
| EPS Basic | -0.12 | -0.30 | -0.36 | -0.70 | -0.61 |
| Normalized Basic EPS | -0.11 | -0.26 | -0.20 | -0.43 | -0.40 |
| EPS Diluted | -0.12 | -0.30 | -0.36 | -0.70 | -0.61 |
| Normalized Diluted EPS | -0.11 | -0.26 | -0.20 | -0.43 | -0.40 |
| Average Basic Shares Outstanding | 16.20M | 12.92M | 9.86M | 8.68M | 7.54M |
| Average Diluted Shares Outstanding | 16.20M | 12.92M | 9.86M | 8.68M | 7.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
